Semaglutide

Semaglutide is a synthetic long-acting glucagon-like peptide-1 (GLP-1) receptor agonist studied for its interaction with GLP-1 receptors in experimental metabolic models. It is structurally modified to enhance stability and receptor affinity, supporting prolonged signaling activity in vitro. Preclinical research utilizes Semaglutide to examine receptor binding kinetics, cAMP-mediated intracellular signaling pathways, and peptide-driven metabolic regulation mechanisms under controlled laboratory conditions.

For research use only. Not for human consumption.

For research use only. Not for human consumption.